Contents Aseptic Fill-Finish for Commercial Pre-Filled Syringe Programmes Supporting Sterile Injectable Formats Manufacturing Site: Maisons-Alfort, France Regulatory Certification and Global Compliance Supply Reliability for Global Programmes Evaluating a European CDMO for Pre-Filled Syringes Discuss Your Programme with Adragos Pharma Pre-Filled […]
Selecting a Contract Development and Manufacturing Organisation for High-Potency Active Pharmaceutical Ingredient small molecule programmes requires a structured, evidence-based evaluation. The critical criteria are: validated Occupational Exposure Band 5 containment, Good Manufacturing Practice certification that explicitly covers the high-potency suite, […]
Pharmaceutical and biotech companies selecting sterile injectable contract development and manufacturing organisation (CDMO) services in Europe must evaluate partners across seven critical dimensions: programme-fit and technical capability, regulatory standing and Good Manufacturing Practice (GMP) certifications, Chemistry, Manufacturing and Controls (CMC) […]
A Strategic Guide to Navigating Early-Stage Fill-Finish for Biologics Optimising early-stage fill-finish for biologics begins at a point where resources are constrained, knowledge is incomplete, and regulatory scrutiny is intense. The central task is to convert a promising molecule into […]
For pharma and biotech companies, selecting a sterile manufacturing partner is about more than equipment or capacity alone. It is about choosing a site that can combine reliable PFS manufacturing, sterile vial production, quality systems and operational support in a way that enables […]
Why small-molecule development risk is often discovered too late Small-molecule development does not usually fail because teams lack effort. It fails because risk is discovered too late. The cost then appears as rework, delayed approvals, or supply plans that collapse […]
Get notified on our latest news.
